Director
Josiah “Jody” Rich, MD, MPH
Deputy Director
Traci Green, PhD, MSc
Contact
Alyssa Pellegrini
Research Program Manager
apellegrini@brownhealth.org
Academic publishing is important to greater scientific understanding of the mechanisms underlying opioid use disorder and for developing innovative solutions. The following publications were supported by the COBRE on Opioids and Overdose funded by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM125507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
2024
Chambers LC, Li Y, Hallowell BD, Langdon KJ, Samuels EA, Mahoney LA, Beaudoin FL, Marshall BDL. Effect of a peer-led emergency department behavioral intervention on non-fatal opioid overdose: 18-month outcome in the Navigator randomized controlled trial. Addiction. 2024 Dec;119(12):2116-2128. doi: 10.1111/add.16581. Epub 2024 Jul 10. PMID: 38987890; PMCID: PMC11568958.
Koehm K, Rosen JG, Yedinak Gray JL, Tardif J, Thompson E, Park JN. “Politics Versus Policy”: Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States. Subst Use Addctn J. 2024 Oct;45(4):682-689. doi: 10.1177/29767342241253663. Epub 2024 May 28. PMID: 38804608; PMCID: PMC11458346.
Messman BA, Compton SE, Majeed I, Weiss NH, Contractor AA. Beyond the mean: examining associations between intraindividual variability in posttraumatic stress disorder symptoms and posttrauma reckless behaviors. Anxiety Stress Coping. 2024 Sep;37(5):615-631. doi: 10.1080/10615806.2024.2307465. Epub 2024 Jan 24. PMID: 38268223; PMCID: PMC11266525.
Hughto JMW, Rich JD, Kelly PJA, Vento SA, Silcox J, Noh M, Pletta DR, Erowid E, Erowid F, Green TC. Preventing overdoses involving stimulants: the POINTS study protocol. BMC Public Health. 2024 Aug 27;24(1):2325. doi: 10.1186/s12889-024-19779-x. PMID: 39192313; PMCID: PMC11348517.
Pappalardo FS, Krieger M, Park C, Beaudoin FL, Wightman RS. Patients presenting to the ED with nonfatal drug overdose: Self-reported history of overdose and naloxone use. Am J Emerg Med. 2024 Aug;82:21-25. doi: 10.1016/j.ajem.2024.05.007. Epub 2024 May 8. PMID: 38759250; PMCID: PMC11254540.
Harvey LH, Green TC, Park JN, Rich JD. U.S. policy responses to xylazine: Thinking bigger. Int J Drug Policy. 2024 Aug;130:104517. doi: 10.1016/j.drugpo.2024.104517. Epub 2024 Jul 12. PMID: 39003892.
Collins AB, Tan M, Smith M, Becker SJ. ‘Everywhere I call, there’s nothing available’: Understanding the alcohol treatment landscape and needs among unstably housed people who use alcohol in Rhode Island. Drug Alcohol Rev. 2024 Jul;43(5):1235-1246. doi: 10.1111/dar.13852. Epub 2024 Apr 16. PMID: 38623042; PMCID: PMC11223957.
Lieberman M, Badea A, Desnoyers C, Hayes K, Park JN. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America. Harm Reduct J. 2024 Jun 15;21(1):115. doi: 10.1186/s12954-024-01025-7. PMID: 38877522; PMCID: PMC11179324.
Contractor AA, Slavish DC, Wang S, Weiss NH. Posttraumatic stress symptoms and positive autobiographical memory characteristics in everyday life. J Trauma Stress. 2024 Jun 4. doi: 10.1002/jts.23064. Epub ahead of print. PMID: 38838082.
Del Pozo B, Park JN, Taylor BG, Wakeman SE, Ducharme L, Pollack HA, Rich JD. Knowledge, Attitudes, and Beliefs About Opioid Use Disorder Treatment in Primary Care. JAMA Netw Open. 2024 Jun 3;7(6):e2419094. doi: 10.1001/jamanetworkopen.2024.19094. PMID: 38941101; PMCID: PMC11214109.
Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC. LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: A structural equation model analysis among people who use drugs in Massachusetts. Drug Alcohol Depend. 2024 Jun 1;259:111293. doi: 10.1016/j.drugalcdep.2024.111293. Epub 2024 Apr 15. PMID: 38643530.
Arbaugh S, Chambers LC, Gaither R, Hallowell BD, Daly MM, Marshall BDL, Beaudoin FL. Association Between Emergency Department Operational Metrics and Substance Use Disorder Treatment Interest in Two Rhode Island Hospitals. R I Med J (2013). 2024 Jul 1;107(7):22-27. PMID: 38917311; PMCID: PMC11476007.
Kelly PJA, Myers-Matthews P, Collins AB, Wolfe HL, Miller-Jacobs C, Davis M, Adrian H, Briody V, Fernández Y, Operario D, Hughto JMW. A qualitative study of reasons to use substances and substance use treatment experiences among transgender and gender diverse adults in Rhode Island. SSM Qual Res Health. 2024 Jun;5:100399. doi: 10.1016/j.ssmqr.2024.100399. Epub 2024 Feb 1. PMID: 38854803; PMCID: PMC11157666.
Park JN, Serafinski R, Ujeneza M, McKenzie M, Tardif J, Krotulski AJ, Badea A, Grossman ER, Green TC. Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study. Drug Alcohol Depend Rep. 2024 Jun 5;11:100247. doi: 10.1016/j.dadr.2024.100247. PMID: 38974777; PMCID: PMC11225690.
Lemen PM, Garrett DP, Thompson E, Aho M, Vasquez C, Park JN. High-dose naloxone formulations are not as essential as we thought. Harm Reduct J. 2024 May 13;21(1):93. doi: 10.1186/s12954-024-00994-z. PMID: 38741224; PMCID: PMC11089786.
Skinner A, Nolen S, Cerdá M, Rich JD, Marshall BDL. A simple heuristic for allocating opioid settlement funding to reduce overdose mortality in the United States. Am J Drug Alcohol Abuse. 2024 May 3;50(3):269-275. doi: 10.1080/00952990.2024.2364338. Epub 2024 Jun 28. PMID: 38940829; PMCID: PMC11305910.
Lopez DS, Parent J, Stegnicki T, Kenyon Z, Arcoleo K, Malloy LC, Mello MJ. Overdosing in a Motor Vehicle: Examination of Human, Geographic, and Environmental Factors. Nurs Res. 2024 May-Jun 01;73(3):195-202. doi: 10.1097/NNR.0000000000000716. Epub 2024 Feb 6. PMID: 38329965; PMCID: PMC11039364.
Song SL, Dandapani HG, Estrada RS, Jones NW, Samuels EA, Ranney ML. Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose. J Addict Med. 2024 May-Jun 01;18(3):218-239. doi: 10.1097/ADM.0000000000001276. Epub 2024 Apr 9. PMID: 38591783; PMCID: PMC11150108.
Miguel-Alvaro A, Messman BA, Weiss NH, Contractor AA. Do childhood experiences influence associations between posttraumatic stress disorder symptoms and positive autobiographical memories among military veteran students? An exploratory study. Memory. 2024 May;32(5):540-551. doi: 10.1080/09658211.2024.2348685. Epub 2024 May 10. PMID: 38727529.
Collins AB, Macon EC, Levin S, Wunsch C, Wightman RS. “It gets you high as a kite but not unsick”: Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island. Int J Drug Policy. 2024 May;127:104391. doi: 10.1016/j.drugpo.2024.104391. Epub 2024 Mar 14. PMID: 38490014; PMCID: PMC11127783.
Dankwah AB, Siegrist RB Jr, Wilson IB, McKenzie M, Rich JD. Attitudes of Black American Christian church leaders toward Opioid Use Disorder, overdoses, and harm reduction: a qualitative study. Front Psychiatry. 2024 Apr 3;15:1359826. doi: 10.3389/fpsyt.2024.1359826. PMID: 38633031; PMCID: PMC11021723.
Rodriguez M, McKenzie M, McKee H, Ledingham EM, John K, Koziol J, Hallowell BD. Differences in Substance Use and Harm Reduction Practices by Race and Ethnicity: Rhode Island Harm Reduction Surveillance System, 2021-2022. J Public Health Manag Pract. 2024 Mar-Apr 01;30(2):E84-E93. doi: 10.1097/PHH.0000000000001863. Epub 2023 Dec 25. PMID: 38153310; PMCID: PMC10872563.
Rosenfield MN, Beaudoin FL, Gaither R, Hallowell BD, Daly MM, Marshall BDL, Chambers LC. Association between comorbid chronic pain or prior hospitalization for mental illness and substance use treatment among a cohort at high risk of opioid overdose. J Subst Use Addict Treat. 2024 Apr;159:209273. doi: 10.1016/j.josat.2023.209273. Epub 2023 Dec 17. PMID: 38113996; PMCID: PMC11457827.
Hughto J, Rich J, Kelly P, Vento S, Silcox J, Noh M, Pletta D, Erowid E, Erowid F, Green T. Preventing Overdoses Involving Stimulants: The POINTS Study Protocol. Res Sq [Preprint]. 2024 Mar 12:rs.3.rs-3993989. doi: 10.21203/rs.3.rs-3993989/v1. Update in: BMC Public Health. 2024 Aug 27;24(1):2325. doi: 10.1186/s12889-024-19779-x. PMID: 38559156; PMCID: PMC10980162.
Scherzer C, Jiménez Muñoz P, Ramsey S, Carey KB, Ranney ML, Clark S, Rich J, Langdon KJ. Perceptions of medications, program settings, and drug use histories among individuals engaged in treatment for opioid use disorder. J Addict Dis. 2024 Jan-Mar;42(1):24-32. doi: 10.1080/10550887.2022.2126273. Epub 2022 Nov 3. PMID: 36325942; PMCID: PMC10154429.
Wolfe HL, Fix GM, Hughto JMW, Hughes LD, Operario D, Hadland SE, Siegel J, Drainoni ML. Understanding how primary care providers report discussing substance use with transgender and gender diverse patients. Patient Educ Couns. 2024 Mar;120:108101. doi: 10.1016/j.pec.2023.108101. Epub 2023 Dec 13. PMID: 38103396; PMCID: PMC10842839.
Rosen JG, Thompson E, Tardif J, Collins AB, Marshall BDL, Park JN. “Make yourself un-NIMBY-able”: stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America. Harm Reduct J. 2024 Feb 15;21(1):40. doi: 10.1186/s12954-024-00955-6. PMID: 38355641; PMCID: PMC10868085.
Moyo P, Nishar S, Merrick C, Streltzov N, Asiedu E, Roma C, Vanjani R, Soske J. Perspectives on Admissions and Care for Residents With Opioid Use Disorder in Skilled Nursing Facilities. JAMA Netw Open. 2024 Feb 5;7(2):e2354746. doi: 10.1001/jamanetworkopen.2023.54746. PMID: 38315484; PMCID: PMC10844991.
Hughto JMW, Wolfe HL, Adrian H, Operario D, Hughes LD, Fernández Y, Briody V, Matthews P, Kelly PJA, Collins AB. Understanding the delivery of substance use treatment services to transgender and gender-diverse people: Findings from a mixed-methods study of healthcare professionals. Soc Sci Med. 2024 Feb;343:116591. doi: 10.1016/j.socscimed.2024.116591. Epub 2024 Jan 18. PMID: 38277762; PMCID: PMC10923070.
Clark SA, Green TC, Rich JD. Pharmacy-based expansion of buprenorphine access. J Subst Use Addict Treat. 2024 Feb;157:209195. doi: 10.1016/j.josat.2023.209195. Epub 2023 Oct 17. PMID: 37858795.
Lu A, Kim C, Rosen JG, Thompson E, Tardif J, Welwean R, Park JN. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs. Subst Use Misuse. 2024;59(4):520-526. doi: 10.1080/10826084.2023.2287195. Epub 2024 Feb 8. PMID: 38044494; PMCID: PMC10922979.
Collins AB, Kaplowitz E, Bastani P, McKee H, Whitaker D, Hallowell BD, McKenzie M. “I Don’t Go Overboard”: Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island. Subst Use Misuse. 2024;59(5):673-679. doi: 10.1080/10826084.2023.2294968. Epub 2023 Dec 20. PMID: 38124349; PMCID: PMC10922331.
Alavi S, Nishar S, Morales A, Vanjani R, Guy A, Soske J. ‘We need to get paid for our value’: Work-place experiences and role definitions of peer recovery specialists/community health workers. Alcohol Treat Q. 2024;42(1):95-114. doi: 10.1080/07347324.2023.2272797. Epub 2023 Dec 3. PMID: 38352063; PMCID: PMC10861181.
2023
Tofighi B, Lopez R, Araujo G, Lee JD, Samuels EA, Wightman RS, Butner J. Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey. J Subst Use. 2024;29(3):347-353. doi: 10.1080/14659891.2023.2166609. Epub 2023 Jan 13. PMID: 39005537; PMCID: PMC11244434.
Reichert J, Del Pozo B, Taylor B. Police Stigma toward People with Opioid Use Disorder: A Study of Illinois Officers. Subst Use Misuse. 2023;58(12):1493-1504. doi: 10.1080/10826084.2023.2227698. Epub 2023 Jun 26. PMID: 37365862; PMCID: PMC10529704.
Cepeda JA, Thompson E, Ujeneza M, Tardif J, Walsh T, Morales A, Rosen JG, Green TC, Park JN. Costing analysis of a point-of-care drug checking program in Rhode Island. Drug Alcohol Depend. 2023 Dec 1;253:111028. doi: 10.1016/j.drugalcdep.2023.111028. Epub 2023 Nov 15. PMID: 38000322; PMCID: PMC11238094.
Weiss NH, Spillane NS, Goldstein SC, Kiefer R, Raudales AM, Nalven T, Egan A, Trinh CD, Moore RS, Gone JP. Ground-up approach to understanding the impacts of historical trauma in one reserve-dwelling first nations community. J Consult Clin Psychol. 2023 Dec;91(12):717-730. doi: 10.1037/ccp0000840. Epub 2023 Aug 31. PMID: 37650826; PMCID: PMC10872583.
Rosen JG, Cepeda J, Park JN. Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States. AIDS. 2023 Nov 15;37(14):2262-2265. doi: 10.1097/QAD.0000000000003688. Epub 2023 Oct 26. PMID: 37877284; PMCID: PMC10605962.
Bhuptani PH, Orchowski LM, Forkus SR, Newberger NG, Weiss NH. The impact of exposure to physical and sexual violence on opioid consequences among trauma-exposed individuals recruited from the community who use opioids. Harm Reduct J. 2023 Nov 11;20(1):167. doi: 10.1186/s12954-023-00901-y. PMID: 37950215; PMCID: PMC10638719.
Chalfin A, Del Pozo B, Mitre-Becerril D. Overdose Prevention Centers, Crime, and Disorder in New York City. JAMA Netw Open. 2023 Nov 1;6(11):e2342228. doi: 10.1001/jamanetworkopen.2023.42228. PMID: 37955901; PMCID: PMC10644216.
Myles ML, Scott K, Ziobrowski HN, Helseth SA, Becker S, Samuels EA. Emergency Department Buprenorphine Quality Improvement and Emergency Physician Knowledge, Attitudes, and Self-Efficacy. West J Emerg Med. 2023 Nov;24(6):1005-1009. doi: 10.5811/westjem.59477. PMID: 38165180; PMCID: PMC10754198.
Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. A survey of North American drug checking services operating in 2022. Int J Drug Policy. 2023 Nov;121:104206. doi: 10.1016/j.drugpo.2023.104206. Epub 2023 Oct 3. PMID: 37797571; PMCID: PMC10843152.
Langdon KJ, Hitch AE, Collins AB, Beckwith CG, Becker S, Tashima K, Rich JD. Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol. Addict Sci Clin Pract. 2023 Oct 14;18(1):60. doi: 10.1186/s13722-023-00418-6. PMID: 37838707; PMCID: PMC10576282.
Collins AB, Macon EC, Langdon K, Joseph R, Thomas A, Dogon C, Beckwith CG. Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island. J Urban Health. 2023 Oct;100(5):1062-1073. doi: 10.1007/s11524-023-00755-6. Epub 2023 Aug 10. PMID: 37563518; PMCID: PMC10618145.
Chatterjee A, Yan S, Lambert A, Morgan JR, Green TC, Jeng PJ, Jalali A, Xuan Z, Krieger M, Marshall BDL, Walley AY, Murphy SM. Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019. Health Serv Res. 2023 Oct;58(5):1141-1150. doi: 10.1111/1475-6773.14200. Epub 2023 Jul 5. PMID: 37408299; PMCID: PMC10480090.
Harvey LH, Green TC, Park JN, Rich JD. Xylazine in the drug supply: A research agenda. Int J Drug Policy. 2023 Oct;120:104190. doi: 10.1016/j.drugpo.2023.104190. Epub 2023 Sep 13. PMID: 37708584; PMCID: PMC10664799.
Welwean RA, Krieg O, Casey G, Thompson E, Fleetham D, Deering T, Rosen JG, Park JN. Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices in North America: a Retrospective Study. J Urban Health. 2023 Oct;100(5):1043-1047. doi: 10.1007/s11524-023-00779-y. Epub 2023 Sep 5. PMID: 37670172; PMCID: PMC10618129.
Friedmann PD, Jawa R, Wilson D, Ramsey SE, Hoskinson R Jr, McKenzie M, Walley AY, Green TC, Bratberg J, Rich JD. Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians. J Addict Med. 2023 Sep-Oct 01;17(5):598-603. doi: 10.1097/ADM.0000000000001190. Epub 2023 Jun 6. PMID: 37788616; PMCID: PMC10593983.
Park JN, Agee T, McCormick S, Felsher M, Collins K, Hsu J, Schweizer N, Lucas G, Falade-Nwulia O. Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis. J Addict Med. 2023 Sep-Oct 01;17(5):608-611. doi: 10.1097/ADM.0000000000001167. Epub 2023 Mar 31. PMID: 37788619; PMCID: PMC10544685.
Harvey L, Rybak N, Rich J. The urgent need for opioid agonist treatment in Russia. Lancet HIV. 2023 Sep;10(9):e559-e560. doi: 10.1016/S2352-3018(23)00177-7. PMID: 37659840; PMCID: PMC11078081.
Wurcel AG, Zubiago J, Reyes J, Smyth E, Balsara KR, Avila D, Barocas JA, Beckwith CG, Bui J, Chastain CA, Eaton EF, Kimmel S, Paras ML, Schranz AJ, Vyas DA, Rapoport A. Surgeons’ Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis. Ann Thorac Surg. 2023 Sep;116(3):492-498. doi: 10.1016/j.athoracsur.2021.12.068. Epub 2022 Jan 31. PMID: 35108502; PMCID: PMC9339044.
Collins AB, Wightman RS, Macon EC, Guan Y, Shihipar A, Krieger M, Elmaleh R, Smith MC, Morales A, Badea A. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island. Int J Drug Policy. 2023 Aug;118:104118. doi: 10.1016/j.drugpo.2023.104118. Epub 2023 Jul 7. PMID: 37422985.
Rosen JG, Toomre T, To C, Olatunde PF, Cooper L, Glick JL, Park JN. Communicative appeals and messaging frames in visual media for HIV pre-exposure prophylaxis promotion to cisgender and transgender women. Cult Health Sex. 2023 Aug;25(8):1007-1023. doi: 10.1080/13691058.2022.2116111. Epub 2022 Sep 8. PMID: 36074902; PMCID: PMC9992445.
Rosen JG, Zhang L, Pelaez D, Park JN, Glick JL. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation. AIDS Behav. 2023 Jul;27(7):2440-2453. doi: 10.1007/s10461-022-03971-4. Epub 2023 Jan 3. Erratum in: AIDS Behav. 2023 Jul;27(7):2454. doi: 10.1007/s10461-023-03999-0. PMID: 36596866; PMCID: PMC9810241.
Nishar S, Brumfield E, Mandal S, Vanjani R, Soske J. “It’s a revolving door”: understanding the social determinants of mental health as experienced by formerly incarcerated people. Health Justice. 2023 Jun 10;11(1):26. doi: 10.1186/s40352-023-00227-8. PMID: 37300627; PMCID: PMC10256957.
Cooper L, Rosen JG, Zhang L, Pelaez D, Olatunde PF, Owczarzak J, Park JN, Glick JL. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study. Harm Reduct J. 2023 Jun 9;20(1):71. doi: 10.1186/s12954-023-00793-y. PMID: 37296423; PMCID: PMC10251329.
Collins AB, Beaudoin FL, Metrik J, Wightman RS. “I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. Drug Alcohol Depend. 2023 May 1;246:109853. doi: 10.1016/j.drugalcdep.2023.109853. Epub 2023 Mar 24. PMID: 36996524; PMCID: PMC10121940.
Weiss NH, Schick MR, Raudales AM, Forkus SR, Thomas ED, Contractor AA, Sullivan TP. Experimental Investigation of the Influence of Positive Emotion Dysregulation on Risky Behavior Following Idiographic Emotion Inductions. Clin Psychol Sci. 2023 May;11(3):490-508. doi: 10.1177/21677026221133295. Epub 2023 Jan 10. PMID: 37576546; PMCID: PMC10420898.
Compton SE, Slavish DC, Weiss NH, Bowen HJ, Contractor AA. Associations between positive memory count and hazardous substance use in a trauma-exposed sample: Examining the moderating role of emotion dysregulation. J Clin Psychol. 2023 May;79(5):1480-1508. doi: 10.1002/jclp.23495. Epub 2023 Mar 2. PMID: 36861379; PMCID: PMC10182872.
Wolfe HL, Hughto JMW, Quint M, Hashemi L, Hughes LD. Hepatitis C Virus Testing and Care Cascade Among Transgender and Gender Diverse Individuals. Am J Prev Med. 2023 May;64(5):695-703. doi: 10.1016/j.amepre.2023.01.005. Epub 2023 Feb 8. PMID: 36759228; PMCID: PMC10121731.
Wang K, Schick MR, Quinn DL, Weiss NH. The Role of Emotion Dysregulation in the Association Between Substance Use Stigma and Depressive Symptoms Among Trauma-Exposed, Substance-Using Individuals. Stigma Health. 2023 May;8(2):243-251. doi: 10.1037/sah0000313. Epub 2021 Apr 15. PMID: 37577451; PMCID: PMC10419118.
Rosen JG, Glick JL, Zhang L, Cooper L, Olatunde PF, Pelaez D, Rouhani S, Sue KL, Park JN. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction. 2023 May;118(5):847-854. doi: 10.1111/add.16103. Epub 2022 Dec 14. PMID: 36468191; PMCID: PMC10073256.
Kiefer R, Goncharenko S, Forkus SR, Contractor AA, LeBlanc N, Weiss NH. Role of positive emotion regulation strategies in the association between childhood trauma and posttraumatic stress disorder among trauma-exposed individuals who use substances. Anxiety Stress Coping. 2023 May;36(3):366-381. doi: 10.1080/10615806.2022.2079636. Epub 2022 May 22. PMID: 35603928; PMCID: PMC9679041.
Channell I, Thomas ED, Forkus SR, Salvatore G, Vieira M, Weiss NH. Religiosity and hazardous substance use: The moderating role of trauma-related shame. Am J Addict. 2023 May;32(3):274-282. doi: 10.1111/ajad.13369. Epub 2022 Dec 26. PMID: 36571570; PMCID: PMC10121753.
Glick JL, Zhang L, Rosen JG, Yaroshevich K, Atiba B, Pelaez D, Park JN. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development. JMIR Form Res. 2023 Apr 13;7:e42418. doi: 10.2196/42418. PMID: 37052977; PMCID: PMC10141312.
Wolfe HL, Drainoni ML, Klasko-Foster L, Fix GM, Siegel J, Mimiaga MJ, Reisner SL, Hughto JMW. Structural Equation Modeling of Stigma and HIV Prevention Clinical Services Among Transgender and Gender Diverse Adults: The Mediating Role of Substance Use and HIV Sexual Risk. J Acquir Immune Defic Syndr. 2023 Apr 1;92(4):300-309. doi: 10.1097/QAI.0000000000003144. PMID: 36515898; PMCID: PMC9974738.
Reyes ME, Simpson L, Sullivan TP, Contractor AA, Weiss NH. Intimate Partner Violence and Mental Health Outcomes Among Hispanic Women in the United States: A Scoping Review. Trauma Violence Abuse. 2023 Apr;24(2):809-827. doi: 10.1177/15248380211043815. Epub 2021 Nov 14. PMID: 34779327.
Griffith J, Yorlets RR, Chambers LC, Davis CS, Wentz A, Beaudoin FL, Baird J, Samuels EA. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019. Am J Public Health. 2023 Apr;113(4):372-377. doi: 10.2105/AJPH.2022.307213. Epub 2023 Feb 6. PMID: 36745856; PMCID: PMC10003491.
Dolan M, Slavish DC, Weiss NH, Contractor AA. The Role of Emotion Dysregulation in the Relationship Between Sleep Disturbances and PTSD Symptom Severity. J Nerv Ment Dis. 2023 Mar 1;211(3):203-215. doi: 10.1097/NMD.0000000000001631. PMID: 36827634; PMCID: PMC9978949.
Chambers LC, Hallowell BD, Samuels EA, Daly M, Baird J, Beaudoin FL. Evaluation of a Statewide Policy to Improve Post-Overdose Care in Emergency Departments and Subsequent Treatment Engagement. R I Med J (2013). 2023 Mar 1;106(2):34-39. PMID: 36848541; PMCID: PMC11457868.
Frueh L, Collins AB, Newman R, Barnett NP, Rich JD, Clark MA, Marshall BDL, Macmadu A. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation. Harm Reduct J. 2023 Feb 4;20(1):14. doi: 10.1186/s12954-023-00741-w. PMID: 36739417; PMCID: PMC9898862.
Goldstein SC, Schick MR, Weyandt LL, Sullivan TP, Saint-Eloi Cadely H, Weiss NH. Posttraumatic stress as a moderator of the association between HPA-axis functioning and alcohol use disorder among a community sample of women currently experiencing intimate partner violence. Exp Clin Psychopharmacol. 2023 Feb;31(1):163-173. doi: 10.1037/pha0000543. Epub 2022 Feb 3. PMID: 35113644; PMCID: PMC10829849.
Green TC, Serafinski R, Clark SA, Rich JD, Bratberg J. Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies. N Engl J Med. 2023 Jan 12;388(2):185-186. doi: 10.1056/NEJMc2208055. PMID: 36630629; PMCID: PMC10075193.
Lombardi AR, Arya R, Rosen JG, Thompson E, Welwean R, Tardif J, Rich JD, Park JN. Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review. Int J Environ Res Public Health. 2023 Jan 10;20(2):1230. doi: 10.3390/ijerph20021230. PMID: 36673987; PMCID: PMC9859116.
Macmadu A, Banks AJ, Hallowell BD, Scagos RP, Hadland SE, Chambers LC, Marshall BDL. Receipt of Prescription Psychostimulants and Stimulant-Involved Fatal Overdose: A Population-Based Case-Control Study. Subst Use Misuse. 2023;58(9):1163-1167. doi: 10.1080/10826084.2023.2212037. Epub 2023 May 11. PMID: 37170622; PMCID: PMC10247490.
Borrelli EP, Bratberg J, Hallowell BD, Kogut SJ. Benzodiazepine Dose Intensity among Patients Concurrently Prescribed Buprenorphine in Rhode Island. Subst Use Misuse. 2023;58(8):1038-1045. doi: 10.1080/10826084.2023.2205492. Epub 2023 May 2. PMID: 37129006.
Bunting AM, Nowotny K, Farabee D, McNeely J, Beckwith CG. Characteristics of Substance Use Screening at Intake in a Sample of U.S. Jails. J Health Care Poor Underserved. 2023;34(1):180-191. doi: 10.1353/hpu.2023.0012. PMID: 37464488; PMCID: PMC10938471.
Irwin AN, Bratberg JP, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Bolivar D, Hansen R, Hartung DM, Green TC. Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):284-294.e1. doi: 10.1016/j.japh.2022.12.001. Epub 2022 Dec 7. PMID: 36567216; PMCID: PMC9933140.
Kaplowitz E, Truong A, Macmadu A, Berk J, Martin H, Burke C, Rich JD, Brinkley-Rubinstein L. Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration. J Addict Med. 2023 Jan-Feb 01;17(1):54-59. doi: 10.1097/ADM.0000000000001029. Epub 2022 Aug 2. PMID: 35916404; PMCID: PMC9892350.
2022
Jacka BP, Nolen S, Bessey SE, Zang X, Goedel WC, Yedinak JL, Marshall BDL. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study. J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):449-452. doi: 10.1097/QAI.0000000000003093. PMID: 36150038; PMCID: PMC9649854.
Hallowell BD, Chambers LC, Samuels EA, Bratberg J, McDonald J, Nitenson A, Onyejekwe C, Beaudoin FL. Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population. Drug Alcohol Depend. 2022 Dec 1;241:109680. doi: 10.1016/j.drugalcdep.2022.109680. Epub 2022 Oct 30. PMID: 36335834; PMCID: PMC10193454.
Hughto JMW, Clark KA, Daken K, Brömdal A, Mullens AB, Sanders T, Phillips T, Mimiaga MJ, Cahill S, du Plessis C, Gildersleeve J, Halliwell SD, Reisner SL. Victimization Within and Beyond the Prison Walls: A Latent Profile Analysis of Transgender and Gender Diverse Adults. J Interpers Violence. 2022 Dec;37(23-24):NP23075-NP23106. doi: 10.1177/08862605211073102. Epub 2022 Feb 23. PMID: 35195466; PMCID: PMC10281010.
Natesan Batley P, Contractor AA, Weiss NH, Compton SE, Price M. Psychometric Evaluation of the Posttrauma Risky Behaviors Questionnaire: Item Response Theory Analyses. Assessment. 2022 Dec;29(8):1824-1841. doi: 10.1177/10731911211036760. Epub 2021 Jul 30. PMID: 34330161; PMCID: PMC9597151.
Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A. Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology. 2022 Dec;1(3):101-112. doi: 10.3390/pharma1030010. Epub 2022 Nov 24. PMID: 36743423; PMCID: PMC9896393.
Weiss NH, Brick LA, Schick MR, Forkus SR, Raudales AM, Contractor AA, Sullivan TP. Posttraumatic stress disorder strengthens the momentary associations between emotion dysregulation and substance use: a micro-longitudinal study of community women experiencing intimate partner violence. Addiction. 2022 Dec;117(12):3150-3169. doi: 10.1111/add.15992. Epub 2022 Jul 25. PMID: 35792057.
Green TC, Olson R, Jarczyk C, Erowid E, Erowid F, Thyssen S, Wightman R, Del Pozo B, Michelson L, Consigli A, Reilly B, Ruiz S. Implementation and Uptake of the Massachusetts Drug Supply Data Stream: A Statewide Public Health-Public Safety Partnership Drug Checking Program. J Public Health Manag Pract. 2022 Nov-Dec 01;28(Suppl 6):S347-S354. doi: 10.1097/PHH.0000000000001581. PMID: 36194805; PMCID: PMC9531987.
Hughto JMW, Moyo P, Green TC. Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder. J Addict Med. 2022 Nov-Dec 01;16(6):616-618. doi: 10.1097/ADM.0000000000000980. PMID: 35245915; PMCID: PMC9433465.
Vanjani R, Soske J, Pitts A, Bailer D. Reflections From Rhode Island’s Safe Consumption Sites Regulations Committee: A Lesson in Racial Equity. J Addict Med. 2022 Nov-Dec 01;16(6):624-626. doi: 10.1097/ADM.0000000000000996. Epub 2022 Jun 27. PMID: 35749752.
Park JN, Sherman SG, Sigmund V, Breaud A, Martin K, Clarke WA. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples. Drug Alcohol Depend. 2022 Nov 1;240:109610. doi: 10.1016/j.drugalcdep.2022.109610. Epub 2022 Aug 31. PMID: 36115223; PMCID: PMC9588631.
Martin RA, Berk J, Rich JD, Kang A, Fritsche J, Clarke JG. Use of long-acting injectable buprenorphine in the correctional setting. J Subst Abuse Treat. 2022 Nov;142:108851. doi: 10.1016/j.jsat.2022.108851. Epub 2022 Jul 29. PMID: 35939914; PMCID: PMC9743485.
Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ. Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study. AIDS Behav. 2022 Oct;26(10):3356-3364. doi: 10.1007/s10461-022-03648-y. Epub 2022 Apr 16. PMID: 35429306; PMCID: PMC10719826.
Macmadu A, Yolken A, Frueh L, Toussaint JR, Newman R, Jacka BP, Collins AB, Marshall BDL. Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island. Harm Reduct J. 2022 Oct 18;19(1):116. doi: 10.1186/s12954-022-00698-2. PMID: 36258209; PMCID: PMC9578237.
Ray B, Hedden BJ, Carroll JJ, Del Pozo B, Wagner K, Kral AH, O’Donnell D, Victor G, Huynh P. Prevalence and correlates of incarceration following emergency medical services response to overdose. Drug Alcohol Depend. 2022 Sep 1;238:109571. doi: 10.1016/j.drugalcdep.2022.109571. Epub 2022 Jul 14. PMID: 35868181; PMCID: PMC10290877.
Macmadu A, Frueh L, Collins AB, Newman R, Barnett NP, Rich JD, Clark MA, Marshall BDL. Drug use behaviors, trauma, and emotional affect following the overdose of a social network member: A qualitative investigation. Int J Drug Policy. 2022 Sep;107:103792. doi: 10.1016/j.drugpo.2022.103792. Epub 2022 Jul 8. PMID: 35816791; PMCID: PMC9462427.
Goldstein SC, Spillane NS, Nalven T, Weiss NH. Harm reduction acceptability and feasibility in a North American indigenous reserve community. J Community Psychol. 2022 Sep;50(8):3607-3624. doi: 10.1002/jcop.22859. Epub 2022 Apr 14. PMID: 35420216; PMCID: PMC9464673.
Morgan JR, Freibott CE, Jalali A, Jeng PJ, Walley AY, Chatterjee A, Green TC, Nolan ML, Linas BP, Marshall BDL, Murphy SM. The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City. Drug Alcohol Depend Rep. 2022 Sep;4:100083. doi: 10.1016/j.dadr.2022.100083. Epub 2022 Jul 27. PMID: 36337350; PMCID: PMC9631422.
Pozo BD. Reducing the Iatrogenesis of Police Overdose Response: Time Is of the Essence. Am J Public Health. 2022 Sep;112(9):1236-1238. doi: 10.2105/AJPH.2022.306987. Epub 2022 Jul 21. PMID: 35862886; PMCID: PMC9382163.
Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R Jr, Bratberg J, Ramsey S, Rich JD, Friedmann PD. Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. J Acquir Immune Defic Syndr. 2022 Aug 15;90(5):546-552. doi: 10.1097/QAI.0000000000003001. PMID: 35587832; PMCID: PMC9283214.
Buchanan A, Sun T, Wu J, Aroke H, Bratberg J, Rich J, Kogut S, Hogan J. Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data. Stat Med. 2022 Aug 15;41(18):3449-3465. doi: 10.1002/sim.9427. Epub 2022 Jun 8. PMID: 35673849; PMCID: PMC9288976.
Compton MT, Krishan S, Broussard B, Bakeman R, Fleischmann MH, Hankerson-Dyson D, Husbands L, Stewart T, D’Orio B, Del Pozo B, Watson AC. Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers’ Mental Health Referrals. Community Ment Health J. 2022 Aug;58(6):1112-1120. doi: 10.1007/s10597-021-00920-8. Epub 2021 Nov 23. PMID: 34812962; PMCID: PMC9197601.
Dauria EF, Kulkarni P, Clemenzi-Allen A, Brinkley-Rubinstein L, Beckwith CG. Interventions Designed to Improve HIV Continuum of Care Outcomes for Persons with HIV in Contact with the Carceral System in the USA. Curr HIV/AIDS Rep. 2022 Aug;19(4):281-291. doi: 10.1007/s11904-022-00609-x. Epub 2022 Jun 8. PMID: 35674879; PMCID: PMC9175158.
Rosen JG, Zhang L, Pelaez D, Coleman JS, To C, Cooper L, Olatunde PF, Toomre T, Glick JL, Park JN. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study. AIDS Patient Care STDS. 2022 Aug;36(8):313-320. doi: 10.1089/apc.2022.0058. PMID: 35951445; PMCID: PMC9419971.
Wightman RS, Nelson LS. Naloxone Dosing in the Era of Fentanyl: The Path Widens by Traveling Down It. Ann Emerg Med. 2022 Aug;80(2):127-129. doi: 10.1016/j.annemergmed.2022.04.014. Epub 2022 May 26. PMID: 35643776.
Berk J, Del Pozo B, Rich JD, Lee JD. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting. J Addict Med. 2022 Jul-Aug 01;16(4):396-398. doi: 10.1097/ADM.0000000000000942. Epub 2021 Dec 23. PMID: 34954747; PMCID: PMC9218006.
Ahmed FZ, Andraka-Christou B, Clark MH, Totaram R, Atkins DN, Del Pozo B. Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost. Health Justice. 2022 Jul 27;10(1):24. doi: 10.1186/s40352-022-00188-4. PMID: 35895179; PMCID: PMC9327334.
Berfield JB, Goncharenko S, Forkus SR, Contractor AA, Weiss NH. The differential relation of trauma types with negative and positive emotion dysregulation. Anxiety Stress Coping. 2022 Jul;35(4):425-439. doi: 10.1080/10615806.2021.1964072. Epub 2021 Aug 9. PMID: 34369816; PMCID: PMC9136915.
Goldberg EM, Rosen RK, Dizon DS, Langdon KJ, Davoodi NM, Wray TB, Nugent NR, Dunsiger SI, Ranney ML. Using Social Media for Clinical Research: Recommendations and Examples From the Brown-Lifespan Center for Digital Health. J Med Internet Res. 2022 Jun 13;24(6):e35804. doi: 10.2196/35804. PMID: 35700012; PMCID: PMC9237766.
Bettano A, Del Pozo B, Bernson D, Barocas JA. Stimulant-related incident surveillance using emergency medical service records in Massachusetts, 2013-2020. Drug Alcohol Depend. 2022 Jun 1;235:109460. doi: 10.1016/j.drugalcdep.2022.109460. Epub 2022 Apr 14. PMID: 35468556; PMCID: PMC9106899.
Gandhi P, Rouhani S, Park JN, Urquhart GJ, Allen ST, Morales KB, Green TC, Sherman SG. Alternative use of buprenorphine among people who use opioids in three U.S. Cities. Subst Abus. 2022;43(1):364-370. doi: 10.1080/08897077.2021.1942395. Epub 2021 Jul 2. PMID: 34214403; PMCID: PMC11216848.
Compton MT, Krishan S, Broussard B, Bakeman R, Fleischmann MH, Hankerson-Dyson D, Husbands L, Stewart T, D’Orio B, Del Pozo B, Watson AC. Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers’ Mental Health Referrals. Community Ment Health J. 2022 Aug;58(6):1112-1120. doi: 10.1007/s10597-021-00920-8. Epub 2021 Nov 23. PMID: 34812962; PMCID: PMC9197601.
Reddon H, Socias ME, Justice A, Cui Z, Nosova E, Barrios R, Fairbairn N, Marshall BDL, Milloy MJ. Periods of Homelessness Linked to Higher VACS Index Among HIV-Positive People Who Use Drugs. AIDS Behav. 2022 Jun;26(6):1739-1749. doi: 10.1007/s10461-021-03524-1. Epub 2022 Jan 22. PMID: 35064852; PMCID: PMC9150923.
Rosenberg NK, Hill AB, Johnsky L, Wiegn D, Merchant RC. Barriers and facilitators associated with establishment of emergency department-initiated buprenorphine for opioid use disorder in rural Maine. J Rural Health. 2022 Jun;38(3):612-619. doi: 10.1111/jrh.12617. Epub 2021 Sep 1. PMID: 34468047; PMCID: PMC10862358.
Hughto JMW, Hughes L, Yee K, Downing J, Ellison J, Alpert A, Jasuja G, Shireman TI. Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data. LGBT Health. 2022 May-Jun;9(4):254-263. doi: 10.1089/lgbt.2021.0433. Epub 2022 Mar 15. PMID: 35290746; PMCID: PMC9150133.
Moyo P, Schmidt C, Lee Y, Joshi R, Mukhdomi T, Trivedi A, Shireman TI. Receipt of Physical Therapy and Chiropractic Care by Adults Diagnosed with Chronic Pain: Analysis of the 2016-2018 Rhode Island All Payer Claims Database. R I Med J (2013). 2022 May 2;105(4):51-56. PMID: 35476739; PMCID: PMC9186019.
Samuels EA, Martin AF. Beyond the Waiver: Multilevel Interventions Needed to Expand Buprenorphine Treatment. JAMA Netw Open. 2022 May 2;5(5):e2212425. doi: 10.1001/jamanetworkopen.2022.12425. PMID: 35552731.
Werb D, Scheim AI, Soipe A, Aeby S, Rammohan I, Fischer B, Hadland SE, Marshall BDL. Health harms of non-medical prescription opioid use: A systematic review. Drug Alcohol Rev. 2022 May;41(4):941-952. doi: 10.1111/dar.13441. Epub 2022 Apr 18. PMID: 35437841; PMCID: PMC9064965.
Weiss NH, Thomas ED, Schick MR, Reyes ME, Contractor AA. Racial and ethnic differences in emotion regulation: A systematic review. J Clin Psychol. 2022 May;78(5):785-808. doi: 10.1002/jclp.23284. Epub 2021 Nov 28. PMID: 34841522; PMCID: PMC9035029.
Jacka BP, Bazerman LB, Dickerson C, Moody M, Martin J, Patry E, Cady T, Compere H, Boudreau M, Beckwith CG. Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges. Int J Drug Policy. 2022 May;103:103668. doi: 10.1016/j.drugpo.2022.103668. Epub 2022 Mar 31. PMID: 35367903; PMCID: PMC9070602.
Collins AB, Edwards S, McNeil R, Goldman J, Hallowell BD, Scagos RP, Marshall BDL. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island. Int J Drug Policy. 2022 May;103:103626. doi: 10.1016/j.drugpo.2022.103626. Epub 2022 Feb 17. PMID: 35228056; PMCID: PMC8849851.
Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JR, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 2022 May;117(5):1372-1381. doi: 10.1111/add.15759. Epub 2021 Dec 5. PMID: 34825427; PMCID: PMC8983544.
Short NA, Evans MK, Raudales AM, Shapiro M, Weiss NH, Schmidt NB. Anxiety sensitivity and cannabis use motives among trauma-exposed young adult cannabis users. Am J Addict. 2022 May;31(3):242-250. doi: 10.1111/ajad.13285. Epub 2022 Apr 1. PMID: 35365953; PMCID: PMC9117414.
Jin L, Keegan FS, Weiss NH, Alghraibeh AM, Aljomaa SS, Almuhayshir AR, Contractor AA. Examining indirect effects of emotion dysregulation between PTSD symptom clusters and reckless/self-destructive behaviors. Psychol Trauma. 2022 May;14(4):688-695. doi: 10.1037/tra0001118. Epub 2021 Sep 9. PMID: 34498900; PMCID: PMC8904644.
Braun HM, Rich JD. A Decentralized Model for Supervised Consumption Services. J Urban Health. 2022 Apr;99(2):332-333. doi: 10.1007/s11524-022-00621-x. Epub 2022 Mar 16. PMID: 35294707; PMCID: PMC9033915.
Samuels EA, Khatri UG, Snyder H, Wightman RS, Tofighi B, Krawczyk N. Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19. J Gen Intern Med. 2022 Apr;37(5):1331-1333. doi: 10.1007/s11606-021-07249-8. Epub 2022 Jan 3. PMID: 34981357; PMCID: PMC8722662.
Marshall BDL, Alexander-Scott N, Yedinak JL, Hallowell BD, Goedel WC, Allen B, Schell RC, Li Y, Krieger MS, Pratty C, Ahern J, Neill DB, Cerdá M. Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial. Addiction. 2022 Apr;117(4):1152-1162. doi: 10.1111/add.15731. Epub 2021 Nov 29. PMID: 34729851; PMCID: PMC8904285.
Kaplowitz E, Macmadu A, Green TC, Berk J, Rich JD, Brinkley-Rubinstein L. “It’s probably going to save my life;” attitudes towards treatment among people incarcerated in the era of fentanyl. Drug Alcohol Depend. 2022 Mar 1;232:109325. doi: 10.1016/j.drugalcdep.2022.109325. Epub 2022 Jan 22. PMID: 35114617; PMCID: PMC9042078.
Hughto JMW, Gordon LK, Stopka TJ, Case P, Palacios WR, Tapper A, Green TC. Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study. Subst Abus. 2022;43(1):465-478. doi: 10.1080/08897077.2021.1946893. Epub 2021 Jul 6. PMID: 34228944; PMCID: PMC9155258.
Weiss NH, Schick MR, Contractor AA, Reyes ME, Suazo NC, Sullivan TP. Racial/Ethnic Differences in Alcohol and Drug Misuse Among IPV-Victimized Women: Exploring the Role of Difficulties Regulating Positive Emotions. J Interpers Violence. 2022 Mar;37(5-6):2826-2850. doi: 10.1177/0886260520943735. Epub 2020 Jul 22. PMID: 32697115.
Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, Doe-Simkins M, Walley AY, Marshall BDL, Bratberg J, Green TC. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Lancet Public Health. 2022 Mar;7(3):e210-e218. doi: 10.1016/S2468-2667(21)00304-2. Epub 2022 Feb 10. PMID: 35151372; PMCID: PMC10937095.
Del Pozo B. CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020. Contemp Drug Probl. 2022 Mar;49(1):3-19. doi: 10.1177/00914509211052107. Epub 2021 Oct 6. PMID: 35068616; PMCID: PMC8782438.
Messman BA, Rafiuddin HS, Slavish DC, Weiss NH, Contractor AA. Examination of daily-level associations between posttraumatic stress disorder symptoms and COVID-19 worries. Psychol Trauma. 2022 Mar;14(3):497-506. doi: 10.1037/tra0001170. Epub 2021 Nov 11. PMID: 34766803; PMCID: PMC10257942.
Nelson-Aguiar RJ, Weiss NH, Swan SC, Sullivan TP. Alcohol Misuse and Women’s Use of Aggression in Intimate Relationships: The Mediating Role of Motivations for Using Aggression. J Interpers Violence. 2022 Mar;37(5-6):2310-2330. doi: 10.1177/0886260520938512. Epub 2020 Jul 9. PMID: 32644858; PMCID: PMC8022282.
Jacka BP, Ziobrowski HN, Lawrence A, Baird J, Wentz AE, Marshall BDL, Wightman RS, Mello MJ, Beaudoin FL, Samuels EA. Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program. Acad Emerg Med. 2022 Mar;29(3):294-307. doi: 10.1111/acem.14409. Epub 2021 Nov 23. PMID: 34738277.
Reyes ME, Rossi JS, Thomas ED, C Goldstein S, Weiss NH. Posttraumatic Stress Disorder and Substance Misuse Among Black Emerging Adults: The Influence of Social Support. J Dual Diagn. 2022 Jan-Mar;18(1):42-51. doi: 10.1080/15504263.2021.2017221. Epub 2021 Dec 31. PMID: 34970948; PMCID: PMC9128832.
Del Pozo B, Rich JD, Carroll JJ. Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome. Int J Drug Policy. 2022 Feb;100:103520. doi: 10.1016/j.drugpo.2021.103520. Epub 2021 Nov 14. PMID: 34785420; PMCID: PMC8810663.
Goedel WC, Macmadu A, Shihipar A, Moyo P, Cerdá M, Marshall BDL. Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study. Int J Drug Policy. 2022 Feb;100:103502. doi: 10.1016/j.drugpo.2021.103502. Epub 2021 Oct 23. PMID: 34695720; PMCID: PMC8810578.
Flam-Ross JM, Lown J, Patil P, White LF, Wang J, Perry A, Bailer D, McKenzie M, Thigpen A, Newman R, Lincoln M, Mckinney T, Bernson D, Barocas JA. Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review. Int J Drug Policy. 2022 Feb;100:103534. doi: 10.1016/j.drugpo.2021.103534. Epub 2021 Dec 9. PMID: 34896932; PMCID: PMC8810696.
Curtis M, Berk J, Larney S, Rich JD, Stoové M. Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison. Int J Drug Policy. 2022 Feb;100:103572. doi: 10.1016/j.drugpo.2021.103572. Epub 2022 Jan 5. PMID: 34998045; PMCID: PMC8810681.
Suazo NC, Reyes ME, Contractor AA, Thomas ED, Weiss NH. Exploring the moderating role of gender in the relation between emotional expressivity and posttraumatic stress disorder symptom severity among Black trauma-exposed college students at a historically Black university. J Clin Psychol. 2022 Feb;78(2):343-356. doi: 10.1002/jclp.23226. Epub 2021 Jul 28. PMID: 34320220; PMCID: PMC8795200.
Dunne EM, Rosen RK, McTigue GL, Jamison RN, Yeh GY, Rich JD, Carey MP. The Lived Experience of Managing HIV and Chronic Pain: Qualitative Interviews with Patients and Healthcare Providers. AIDS Behav. 2022 Feb;26(2):496-511. doi: 10.1007/s10461-021-03406-6. Epub 2021 Aug 4. PMID: 34350531; PMCID: PMC8827137.
Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR, Walley AY. Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug Alcohol Depend. 2022 Jan 1;230:109190. doi: 10.1016/j.drugalcdep.2021.109190. Epub 2021 Nov 27. PMID: 34864356; PMCID: PMC8714703.
Weiss NH, Kiefer R, Goncharenko S, Raudales AM, Forkus SR, Schick MR, Contractor AA. Emotion regulation and substance use: A meta-analysis. Drug Alcohol Depend. 2022 Jan 1;230:109131. doi: 10.1016/j.drugalcdep.2021.109131. Epub 2021 Oct 27. PMID: 34864568; PMCID: PMC8714680.
Del Pozo B. “ARREST ALL STREET MENDICANTS AND BEGGARS:” HOMELESSNESS, SOCIAL COOPERATION, AND THE COMMITMENTS OF DEMOCRATIC POLICING. Am Crim Law Rev. 2022 Fall;54(4):1681-1696. PMID: 35663245; PMCID: PMC9161507.
Wang K, Schick MR, Weiss NH. The role of executive functioning deficits in the association between substance-use-related stigma and substance use problems among trauma-exposed individuals. Subst Abus. 2022;43(1):171-178. doi: 10.1080/08897077.2021.1903652. Epub 2021 Mar 24. PMID: 33759728; PMCID: PMC8460690.
Harvey TD, Hughto JMW, Clark KA. Availability of Accessible Representative Health Data to Examine Sexual and Gender Minority Disparities in Incarceration and Its Health Implications in the United States, 2010-2020. LGBT Health. 2022 Feb-Mar;9(2):81-93. doi: 10.1089/lgbt.2021.0090. Epub 2022 Feb 15. PMID: 35167353; PMCID: PMC9022180.
Andraka-Christou B, Clark MH, Atkins DN, Del Pozo B. Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder. Subst Abus. 2022;43(1):425-432. doi: 10.1080/08897077.2021.1944958. Epub 2021 Jul 8. PMID: 34236297; PMCID: PMC9518695.
Contractor AA, Banducci AN, Weiss NH. Critical considerations for the positive memory-posttraumatic stress disorder model. Clin Psychol Psychother. 2022 Jan;29(1):81-91. doi: 10.1002/cpp.2599. Epub 2021 Apr 22. PMID: 33870586.
2021
Del Pozo B, Sightes E, Goulka J, Ray B, Wood CA, Siddiqui S, Beletsky LA. Police discretion in encounters with people who use drugs: operationalizing the theory of planned behavior. Harm Reduct J. 2021 Dec 16;18(1):132. doi: 10.1186/s12954-021-00583-4. PMID: 34915910; PMCID: PMC8675297.
Langdon KJ, Scherzer C, Ramsey S, Carey K, Rich J, Ranney ML. Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder. J Subst Abuse Treat. 2021 Dec;131:108538. doi: 10.1016/j.jsat.2021.108538. Epub 2021 Jun 16. PMID: 34154869; PMCID: PMC8664978.
Bernstein MH, Rosenfield M, Fuchs N, Magill M, Blease CR, Beaudoin FL, Rich JD, Wartolowska K, Terek RM. How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use. J Psychosom Res. 2021 Dec;151:110638. doi: 10.1016/j.jpsychores.2021.110638. Epub 2021 Oct 5. PMID: 34644614; PMCID: PMC8633179.
Wightman RS, Jacka B, Uber J, McKenzie M, Reddy NG, Winters R, Jordison Keeler LA, Samuels EA. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation. Am J Emerg Med. 2021 Dec;50:409-412. doi: 10.1016/j.ajem.2021.08.071. Epub 2021 Aug 28. PMID: 34481260; PMCID: PMC8665045.
Del Pozo B, Sightes E, Kang S, Goulka J, Ray B, Beletsky LA. Can touch this: training to correct police officer beliefs about overdose from incidental contact with fentanyl. Health Justice. 2021 Nov 24;9(1):34. doi: 10.1186/s40352-021-00163-5. PMID: 34817717; PMCID: PMC8612110.
Weiss NH, Hogan J, Brem M, Massa AA, Kirby CM, Flanagan JC. Advancing our understanding of the intersection between emotion regulation and alcohol and drug use problems: Dyadic analysis in couples with intimate partner violence and alcohol use disorder. Drug Alcohol Depend. 2021 Nov 1;228:109066. doi: 10.1016/j.drugalcdep.2021.109066. Epub 2021 Sep 24. PMID: 34610519; PMCID: PMC8595860.
Murphy M, Ding A, Berk J, Rich J, Bayliss G. Kidney Disease among People Who Are Incarcerated. Clin J Am Soc Nephrol. 2021 Nov;16(11):1766-1772. doi: 10.2215/CJN.01910221. Epub 2021 Jun 16. PMID: 34135025; PMCID: PMC8729426.
Bernstein MH, Fuchs N, Rosenfield M, Weiss AP, Blease C, Locher C, Magill M, Rich J, Beaudoin FL. Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients. J Pain. 2021 Nov;22(11):1518-1529. doi: 10.1016/j.jpain.2021.05.001. Epub 2021 May 15. PMID: 34004348; PMCID: PMC8578133.
Collins AB, Beaudoin FL, Samuels EA, Wightman R, Baird J. Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation. J Subst Abuse Treat. 2021 Nov;130:108411. doi: 10.1016/j.jsat.2021.108411. Epub 2021 Apr 14. PMID: 34118703.
Wightman RS, Erowid E, Erowid F, Thyssen S, Wheeler M, Pulminskas B, Olson R, Green TC. Confirmed reports of bupropion sold as crack cocaine in the illicit drug supply. Clin Toxicol (Phila). 2021 Nov;59(11):1031-1032. doi: 10.1080/15563650.2021.1898632. Epub 2021 Mar 31. PMID: 33784932.
Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, Bazzi AR. Supervised Injection Facilities as Harm Reduction: A Systematic Review. Am J Prev Med. 2021 Nov;61(5):738-749. doi: 10.1016/j.amepre.2021.04.017. Epub 2021 Jul 1. PMID: 34218964; PMCID: PMC8541900.
Wightman RS, Perrone J, Scagos R, Hallowell BD, Krieger M, Li Y, McGregor AJ, Nelson LS, Marshall BDL. Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose death. Drug Alcohol Depend. 2021 Oct 1;227:108994. doi: 10.1016/j.drugalcdep.2021.108994. Epub 2021 Aug 28. PMID: 34482038; PMCID: PMC8464519.
Yedinak JL, Li Y, Krieger MS, Howe K, Ndoye CD, Lee H, Civitarese AM, Marak T, Nelson E, Samuels EA, Chan PA, Bertrand T, Marshall BDL. Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak. Int J Drug Policy. 2021 Oct;96:103395. doi: 10.1016/j.drugpo.2021.103395. Epub 2021 Jul 31. PMID: 34344539; PMCID: PMC8568646.
Lopez-Vergara HI, Yang M, Weiss NH, Stamates AL, Spillane NS, Feldstein Ewing SW. The cultural equivalence of measurement in substance use research. Exp Clin Psychopharmacol. 2021 Oct;29(5):456-465. doi: 10.1037/pha0000512. Epub 2021 Jul 5. PMID: 34242041; PMCID: PMC8511178.
Collins AB, Beaudoin FL, Samuels EA, Wightman R, Baird J. The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report. J Addict Med. 2021 Sep-Oct 01;15(5):432-434. doi: 10.1097/ADM.0000000000000779. PMID: 33201002; PMCID: PMC8489579.
Macmadu A, Batthala S, Correia Gabel AM, Rosenberg M, Ganguly R, Yedinak JL, Hallowell BD, Scagos RP, Samuels EA, Cerdá M, Paull K, Marshall BDL. Comparison of Characteristics of Deaths From Drug Overdose Before vs During the COVID-19 Pandemic in Rhode Island. JAMA Netw Open. 2021 Sep 1;4(9):e2125538. doi: 10.1001/jamanetworkopen.2021.25538. PMID: 34533569; PMCID: PMC8449276.
Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC. Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019. Harm Reduct J. 2021 Aug 30;18(1):93. doi: 10.1186/s12954-021-00538-9. PMID: 34461922; PMCID: PMC8404353.
Howell BA, Martin RA, Lebeau R, Truong AQ, Wang EA, Rich JD, Clarke JG. Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System. Health Aff (Millwood). 2021 Aug;40(8):1304-1311. doi: 10.1377/hlthaff.2020.02156. PMID: 34339247; PMCID: PMC9036835.
Samuels EA, Wentz A, McCormick M, McDonald JV, Marshall BDL, Friedman C, Koziol J, Alexander-Scott NE. Rhode Island’s Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment. Ann Emerg Med. 2021 Jul;78(1):68-79. doi: 10.1016/j.annemergmed.2021.02.004. Epub 2021 Apr 15. PMID: 33865617; PMCID: PMC9119858.
Wolfe HL, Biello KB, Reisner SL, Mimiaga MJ, Cahill SR, Hughto JMW. Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults. Drug Alcohol Depend. 2021 Jun 1;223:108711. doi: 10.1016/j.drugalcdep.2021.108711. Epub 2021 Apr 20. PMID: 33866073; PMCID: PMC8114322.
Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health Professional Stigma as a Barrier to Contingency Management Implementation in Opioid Treatment Programs. Transl Issues Psychol Sci. 2021 Jun;7(2):166-176. doi: 10.1037/tps0000245. Epub 2020 Oct 15. PMID: 34485617; PMCID: PMC8412039.
Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, Green TC, Clarke JG, Rich JD. Fentanyl-related overdose during incarceration: a comprehensive review. Health Justice. 2021 May 19;9(1):13. doi: 10.1186/s40352-021-00138-6. PMID: 34013442; PMCID: PMC8133055.
Schick MR, Weiss NH, Contractor AC, Thomas ED, Spillane NS. Positive emotional intensity and substance use: the underlying role of positive emotional avoidance in a community sample of military veterans. Am J Drug Alcohol Abuse. 2021 May 4;47(3):373-382. doi: 10.1080/00952990.2020.1868488. Epub 2021 Feb 1. PMID: 33524279; PMCID: PMC10909499.
Crable EL, Blue TR, McKenzie M, Rich JD, Gordon MS. Effect of Case Management on HIV Outcomes for Community Corrections Population: Results of an 18-Month Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2021 May 1;87(1):755-762. doi: 10.1097/QAI.0000000000002624. PMID: 33492021; PMCID: PMC8026504.
Hughto JMW, Restar AJ, Wolfe HL, Gordon LK, Reisner SL, Biello KB, Cahill SR, Mimiaga MJ. Opioid pain medication misuse, concomitant substance misuse, and the unmet behavioral health treatment needs of transgender and gender diverse adults. Drug Alcohol Depend. 2021 May 1;222:108674. doi: 10.1016/j.drugalcdep.2021.108674. Epub 2021 Mar 18. PMID: 33773869; PMCID: PMC8058310.
Clark SA, Davis C, Wightman RS, Wunsch C, Keeler LAJ, Reddy N, Samuels EA. Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island. J Subst Abuse Treat. 2021 May;124:108283. doi: 10.1016/j.jsat.2021.108283. Epub 2021 Jan 20. PMID: 33771282; PMCID: PMC7817486.
Macmadu A, Adams JW, Bessey SE, Brinkley-Rubinstein L, Martin RA, Clarke JG, Green TC, Rich JD, Marshall BDL. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study. Int J Drug Policy. 2021 May;91:102841. doi: 10.1016/j.drugpo.2020.102841. Epub 2020 Jul 22. PMID: 32712165; PMCID: PMC7790977.
Richardson L, Laing A, Choi J, Nosova E, Milloy MJ, Marshall BD, Singer J, Wood E, Kerr T. Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial. Lancet Public Health. 2021 May;6(5):e324-e334. doi: 10.1016/S2468-2667(21)00023-2. Epub 2021 Apr 12. PMID: 33857455; PMCID: PMC8176782.
Del Pozo B. Complexity, Lethality, and the Perverse Imagination: Modelling Nonstate Actors’ Means of Attack. Stud Confl Terror. 2023;46(11):2351-2362. doi: 10.1080/1057610X.2021.1906483. Epub 2021 Apr 12. PMID: 38152551; PMCID: PMC10750963.
Papp MA, Leff JA, Murphy SM, Yang A, Crane HM, Metsch LR, Del Rio C, Feaster DJ, Rich JD, Schackman BR, McCollister KE. Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research. Subst Abuse Treat Prev Policy. 2021 Apr 8;16(1):32. doi: 10.1186/s13011-021-00356-z. PMID: 33832483; PMCID: PMC8033702.
Scott K, Jarman S, Moul S, Murphy CM, Yap K, Garner BR, Becker SJ. Implementation support for contingency management: preferences of opioid treatment program leaders and staff. Implement Sci Commun. 2021 Apr 30;2(1):47. doi: 10.1186/s43058-021-00149-2. PMID: 33931126; PMCID: PMC8088083.
Green TC, Kaplowitz E, Langdon K, Hughto JMW, Goedel WC, Czynski AJ, Fraser G, Rich J. COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond. R I Med J (2013). 2021 Apr 1;104(3):22-26. PMID: 33789404; PMCID: PMC8049088.
Aroke HA, Buchanan AL, Bratberg J, Hogan JW, Rich JD, Wen X, Kogut SJ. Initial Patterns of Prescription Opioid Supply and Risk of Mortality Among Insured Adults in the United States. J Addict Med. 2021 Apr 1;15(2):99-108. doi: 10.1097/ADM.0000000000000701. PMID: 32769771; PMCID: PMC8288109.
Jacka B, Beaudoin F, Li Y, Nimaja E, Yedinak J, Samuels E, Marshall BDL. Objective Outcome Measures in Randomized Clinical Trials of Interventions to Reduce Risk of Opioid Overdose Following Discharge From the Emergency Department: Utility of Administrative Data Linkage. J Addict Med. 2021 Apr 1;15(2):174-175. doi: 10.1097/ADM.0000000000000705. PMID: 32769773; PMCID: PMC7994945.
Del Pozo B, Beletsky L, Goulka J, Kleinig J. Beyond Decriminalization: Ending the War on Drugs Requires Recasting Police Discretion through the Lens of a Public Health Ethic. Am J Bioeth. 2021 Apr;21(4):41-44. doi: 10.1080/15265161.2021.1891339. PMID: 33825640; PMCID: PMC9298531.
Goulka J, Del Pozo B, Beletsky L. From public safety to public health: Re-envisioning the goals and methods of policing. J Community Saf Well Being. 2021 Mar 19;6(1):22-27. doi: 10.35502/jcswb.184. PMID: 34660886; PMCID: PMC8516139.
Mimiaga MJ, Hughto JMW, Klasko-Foster L, Jin H, Mayer KH, Safren SA, Biello KB. Substance Use, Mental Health Problems, and Physical and Sexual Violence Additively Increase HIV Risk Between Male Sex Workers and Their Male Clients in Northeastern United States. J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):305-312. doi: 10.1097/QAI.0000000000002563. PMID: 33148992; PMCID: PMC8343953.
Macmadu A, Paull K, Youssef R, Batthala S, Wilson KH, Samuels EA, Yedinak JL, Marshall BDL. Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study. Drug Alcohol Depend. 2021 Feb 1;219:108435. doi: 10.1016/j.drugalcdep.2020.108435. Epub 2020 Nov 23. PMID: 33310383; PMCID: PMC7855664.
Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults. JAMA Netw Open. 2021 Feb 1;4(2):e2036512. doi: 10.1001/jamanetworkopen.2020.36512. Erratum in: JAMA Netw Open. 2021 Mar 1;4(3):e213314. doi: 10.1001/jamanetworkopen.2021.3314. PMID: 33538824; PMCID: PMC7862992.
Del Pozo B, Rich JD. Addressing Racism in Medicine Requires Tackling the Broader Problem of Epistemic Injustice. Am J Bioeth. 2021 Feb;21(2):90-93. doi: 10.1080/15265161.2020.1861367. PMID: 33534692; PMCID: PMC7904098.
Wightman RS, Perrone J, Scagos R, Krieger M, Nelson LS, Marshall BDL. Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis. J Med Toxicol. 2021 Jan;17(1):10-15. doi: 10.1007/s13181-020-00795-3. Epub 2020 Jul 9. PMID: 32648229; PMCID: PMC7785599.
Kimmel SD, Gaeta JM, Hadland SE, Hallett E, Marshall BDL. Principles of Harm Reduction for Young People Who Use Drugs. Pediatrics. 2021 Jan;147(Suppl 2):S240-S248. doi: 10.1542/peds.2020-023523G. PMID: 33386326; PMCID: PMC7907587.
Hughto JMW, Peterson L, Perry NS, Donoyan A, Mimiaga MJ, Nelson KM, Pantalone DW. The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19. J Subst Abuse Treat. 2021 Jan;120:108163. doi: 10.1016/j.jsat.2020.108163. Epub 2020 Oct 9. PMID: 33298301; PMCID: PMC7545305.
2020
Del Pozo B, Rich JD. Revising our attitudes towards agonist medications and their diversion in a time of pandemic. J Subst Abuse Treat. 2020 Dec;119:108139. doi: 10.1016/j.jsat.2020.108139. Epub 2020 Sep 21. PMID: 33138924; PMCID: PMC7505066.
Jin H, Marshall BDL, Degenhardt L, Strang J, Hickman M, Fiellin DA, Ali R, Bruneau J, Larney S. Global opioid agonist treatment: a review of clinical practices by country. Addiction. 2020 Dec;115(12):2243-2254. doi: 10.1111/add.15087. Epub 2020 May 19. PMID: 32289189; PMCID: PMC7554123.
Gaur DS, Jacka BP, Green TC, Samuels EA, Hadland SE, Krieger MS, Yedinak JL, Marshall BDL. US drug overdose mortality: 2009-2018 increases affect young people who use drugs. Int J Drug Policy. 2020 Nov;85:102906. doi: 10.1016/j.drugpo.2020.102906. Epub 2020 Oct 16. PMID: 33070095; PMCID: PMC7769862.
Park JN, Tomko C, Silberzahn BE, Haney K, Marshall BDL, Sherman SG. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study. Addict Behav. 2020 Nov;110:106529. doi: 10.1016/j.addbeh.2020.106529. Epub 2020 Jun 27. PMID: 32683172; PMCID: PMC8214920.
Borrelli EP, Morphis B, Youssef R, Chambers LC, Hallowell BD, Bratberg J, Kogut SJ. Concurrent Utilization of Prescription Opioids and Non-opioid Controlled Substances: Rhode Island Prescription Drug Monitoring Program, 2018. R I Med J (2013). 2020 Oct 1;103(8):53-58. PMID: 33003681.
Anderson TS, Krieger MS, Marshall BDL, Cerdá M, Hadland S. Financial Payments to Teaching Hospitals by Companies Marketing Opioids. J Gen Intern Med. 2020 Oct;35(10):3108-3110. doi: 10.1007/s11606-019-05596-1. Epub 2019 Dec 17. PMID: 31848860; PMCID: PMC7572903.
Hughto JMW, Gunn HA, Rood BA, Pantalone DW. Social and Medical Gender Affirmation Experiences Are Inversely Associated with Mental Health Problems in a U.S. Non-Probability Sample of Transgender Adults. Arch Sex Behav. 2020 Oct;49(7):2635-2647. doi: 10.1007/s10508-020-01655-5. Epub 2020 Mar 25. PMID: 32215775; PMCID: PMC7494544.
Del Pozo B, Beletsky L, Rich JD. COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform. J Addict Med. 2020 Sep/Oct;14(5):e144-e146. doi: 10.1097/ADM.0000000000000703. PMID: 32604133; PMCID: PMC9204673.
Jin L, Dolan M, Contractor A, Weiss NH, Dranger P. Relations between Emotional Expressivity Dimensions and DSM-5 PTSD Symptom Clusters in a Trauma-Exposed Community Sample. Behav Change. 2020 Sep;37(3):116-129. doi: 10.1017/bec.2020.7. Epub 2020 Jun 11. PMID: 33776199; PMCID: PMC7995860.
Pachankis JE, Clark KA, Burton CL, Hughto JMW, Bränström R, Keene DE. Sex, status, competition, and exclusion: Intraminority stress from within the gay community and gay and bisexual men’s mental health. J Pers Soc Psychol. 2020 Sep;119(3):713-740. doi: 10.1037/pspp0000282. Epub 2020 Jan 13. PMID: 31928026; PMCID: PMC7354883.
Del Pozo B, Rawson RA. Putting the Horse Before the Unicorn: A Safe Supply Strategy Should Begin With Partial Agonists–A Commentary on Bonn et al. (2020). J Stud Alcohol Drugs. 2020 Sep;81(5):562-563. doi: 10.15288/jsad.2020.81.562. PMID: 33028467; PMCID: PMC8076491.
Hadland SE, Jent VA, Alinsky RH, Marshall BDL, Mauro PM, Cerdá M. Opioid Use Disorder Treatment Facilities With Programs for Special Populations. Am J Prev Med. 2020 Sep;59(3):e125-e133. doi: 10.1016/j.amepre.2020.03.022. Epub 2020 May 21. PMID: 32448551; PMCID: PMC7484197.
Del Pozo B, Beletsky L. No “back to normal” after COVID-19 for our failed drug policies. Int J Drug Policy. 2020 Sep;83:102901. doi: 10.1016/j.drugpo.2020.102901. Epub 2020 Aug 11. PMID: 32807624; PMCID: PMC7418724.
Banducci AN, Contractor AA, Weiss NH, Dranger P. Do positive memory characteristics relate to reckless behaviours? an exploratory study in a treatment-seeking traumatised sample. Memory. 2020 Aug;28(7):950-956. doi: 10.1080/09658211.2020.1788603. Epub 2020 Jul 7. PMID: 32633631; PMCID: PMC7484292.
Banducci AN, Weiss NH. Caring for patients with posttraumatic stress and substance use disorders during the COVID-19 pandemic. Psychol Trauma. 2020 Aug;12(S1):S113-S114. doi: 10.1037/tra0000824. Epub 2020 Jun 11. PMID: 32525388; PMCID: PMC7451398.
Irvine M, Coombs D, Skarha J, Del Pozo B, Rich J, Taxman F, Green TC. Modeling COVID-19 and Its Impacts on U.S. Immigration and Customs Enforcement (ICE) Detention Facilities, 2020. J Urban Health. 2020 Aug;97(4):439-447. doi: 10.1007/s11524-020-00441-x. PMID: 32415422; PMCID: PMC7228433.
Stone AC, Carroll JJ, Rich JD, Green TC. One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission. J Subst Abuse Treat. 2020 Aug;115:108031. doi: 10.1016/j.jsat.2020.108031. Epub 2020 May 11. PMID: 32600619; PMCID: PMC10347815.
Truong AQ, Patil S, Rich JD. Prescribers and Naloxone Pharmacy Claims. J Gen Intern Med. 2020 Aug;35(8):2474. doi: 10.1007/s11606-020-05760-y. Epub 2020 Mar 19. PMID: 32193816; PMCID: PMC7403247.
Samuels EA, Clark SA, Wunsch C, Jordison Keeler LA, Reddy N, Vanjani R, Wightman RS. Innovation During COVID-19: Improving Addiction Treatment Access. J Addict Med. 2020 Jul/Aug;14(4):e8-e9. doi: 10.1097/ADM.0000000000000685. PMID: 32404652; PMCID: PMC7236851.
Delcher C, Pauly N, Moyo P. Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019). Curr Opin Psychiatry. 2020 Jul;33(4):326-333. doi: 10.1097/YCO.0000000000000608. PMID: 32250984; PMCID: PMC7409839.
Pozo BD, Krasner LS, George SF. Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths. J Law Med Ethics. 2020 Jun;48(2):373-375. doi: 10.1177/1073110520935353. PMID: 32631187; PMCID: PMC9197600.
Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nat Med. 2020 Jun;26(6):819-820. doi: 10.1038/s41591-020-0898-0. PMID: 32555514; PMCID: PMC8600654.
Salisbury-Afshar EM, Rich JD, Adashi EY. Vulnerable Populations: Weathering the Pandemic Storm. Am J Prev Med. 2020 Jun;58(6):892-894. doi: 10.1016/j.amepre.2020.04.002. Epub 2020 Apr 22. PMID: 32371018; PMCID: PMC7174188.
Goldman JE, Samuels EA, Rich JD, Marshall BDL. Correlates of death during outpatient treatment for opioid use disorder: A national study. J Subst Abuse Treat. 2020 May;112:76-85. doi: 10.1016/j.jsat.2020.01.003. Epub 2020 Jan 15. PMID: 32199549; PMCID: PMC10395190.
Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Trends in opioid initiation among people who use opioids in three US cities. Drug Alcohol Rev. 2020 May;39(4):375-383. doi: 10.1111/dar.13060. Epub 2020 Apr 6. PMID: 32249463.
Langdon KJ, Ramsey S, Scherzer C, Carey K, Ranney ML, Rich J. Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder. Addict Sci Clin Pract. 2020 Apr 29;15(1):16. doi: 10.1186/s13722-020-00189-4. PMID: 32349790; PMCID: PMC7191734.
Goedel WC, Shapiro A, Cerdá M, Tsai JW, Hadland SE, Marshall BDL. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States. JAMA Netw Open. 2020 Apr 1;3(4):e203711. doi: 10.1001/jamanetworkopen.2020.3711. PMID: 32320038; PMCID: PMC7177200.
Hadland SE, Cerdá M, Earlywine JJ, Krieger MS, Anderson TS, Marshall BDL. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018. JAMA Pediatr. 2020 Apr 1;174(4):385-387. doi: 10.1001/jamapediatrics.2019.5526. PMID: 31961384; PMCID: PMC6990909.
Mimiaga MJ, August Oddleifson D, Meersman SC, Silvia A, Hughto JMW, Landers S, Brown E, Loberti P. Multilevel Barriers to Engagement in the HIV Care Continuum Among Residents of the State of Rhode Island Living with HIV. AIDS Behav. 2020 Apr;24(4):1133-1150. doi: 10.1007/s10461-019-02677-4. PMID: 31563986; PMCID: PMC7085442.
Carroll JJ, Rich JD, Green TC. The protective effect of trusted dealers against opioid overdose in the U.S. Int J Drug Policy. 2020 Apr;78:102695. doi: 10.1016/j.drugpo.2020.102695. Epub 2020 Mar 4. PMID: 32143185; PMCID: PMC7302982.
Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Clin Infect Dis. 2020 Mar 3;70(6):1096-1102. doi: 10.1093/cid/ciz321. PMID: 31143944; PMCID: PMC7319062.
Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, Martin RA, Rich JD, Marshall BDL. Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug Alcohol Depend. 2020 Mar 1;208:107858. doi: 10.1016/j.drugalcdep.2020.107858. Epub 2020 Jan 18. PMID: 32050112; PMCID: PMC7075016.
King WM, Hughto JMW, Operario D. Transgender stigma: A critical scoping review of definitions, domains, and measures used in empirical research. Soc Sci Med. 2020 Feb 21;250:112867. doi: 10.1016/j.socscimed.2020.112867. Epub ahead of print. PMID: 32163820; PMCID: PMC7442603.
Brinkley-Rubinstein L, Allen SA, Rich JD. Incarceration and the health of detained children. Lancet Public Health. 2020 Feb;5(2):e76-e77. doi: 10.1016/S2468-2667(19)30250-6. Epub 2020 Jan 16. PMID: 31954436; PMCID: PMC10249760.
Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. Opioid use disorder. Nat Rev Dis Primers. 2020 Jan 9;6(1):3. doi: 10.1038/s41572-019-0137-5. PMID: 31919349.
Kravitz-Wirtz N, Davis CS, Ponicki WR, Rivera-Aguirre A, Marshall BDL, Martins SS, Cerdá M. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States. JAMA Netw Open. 2020 Jan 3;3(1):e1919066. doi: 10.1001/jamanetworkopen.2019.19066. PMID: 31922561; PMCID: PMC6991255.
2019
Brinkley-Rubinstein L, Peterson M, Clarke J, Macmadu A, Truong A, Pognon K, Parker M, Marshall BDL, Green T, Martin R, Stein L, Rich JD. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting. Drug Alcohol Depend. 2019 Dec 1;205:107514. doi: 10.1016/j.drugalcdep.2019.06.016. Epub 2019 Oct 7. PMID: 31614328; PMCID: PMC10347877.
Jadwin-Cakmak L, Reisner SL, Hughto JMW, Salomon L, Martinez M, Popoff E, Rivera BA, Harper GW. HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S. BMC Public Health. 2019 Nov 15;19(1):1531. doi: 10.1186/s12889-019-7605-4. PMID: 31730450; PMCID: PMC6858737.
Goedel WC, Marshall BDL, Samuels EA, Brinkman MG, Dettor D, Langdon KJ, Mahoney LA, Merchant RC, Nizami T, O’Toole GA, Ramsey SE, Yedinak JL, Beaudoin FL. Randomised clinical trial of an emergency department-based peer recovery support intervention to increase treatment uptake and reduce recurrent overdose among individuals at high risk for opioid overdose: study protocol for the navigator trial. BMJ Open. 2019 Nov 11;9(11):e032052. doi: 10.1136/bmjopen-2019-032052. PMID: 31719087; PMCID: PMC6858243.
Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, Buchanan AL, Coderre T, Boss R, Rich JD, Marshall BDL. Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment. PLoS Med. 2019 Nov 19;16(11):e1002963. doi: 10.1371/journal.pmed.1002963. PMID: 31743335; PMCID: PMC6863520.
Peterson M, Macmadu A, Truong AQ, Rich J, Pognon K, Lurie M, Clarke JG, Brinkley-Rubinstein L. Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island. J Subst Abuse Treat. 2019 Nov;106:73-78. doi: 10.1016/j.jsat.2019.08.015. Epub 2019 Aug 28. PMID: 31540614; PMCID: PMC10347805.
Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, Bruneau J, Altice FL, Henderson G, Rahimi-Movaghar A, Larney S. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019 Oct 26;394(10208):1560-1579. doi: 10.1016/S0140-6736(19)32229-9. Epub 2019 Oct 23. PMID: 31657732; PMCID: PMC7068135.
Lam JA, Lee HIS, Truong AQ, Macmadu A, Clarke JG, Rich J, Brockmann B. Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting. J Subst Abuse Treat. 2019 Sep;104:28-33. doi: 10.1016/j.jsat.2019.06.001. Epub 2019 Jun 10. PMID: 31370982; PMCID: PMC6684325.
Krieger D, Abe C, Pottorff A, Li X, Rich J, Nijhawan AE. Sexually Transmitted Infections Detected During and After Incarceration Among People with Human Immunodeficiency Virus: Prevalence and Implications for Screening and Prevention. Sex Transm Dis. 2019 Sep;46(9):602-607. doi: 10.1097/OLQ.0000000000001023. PMID: 31415042; PMCID: PMC6702963.
Goedel WC, Marshall BDL, Spangler KR, Alexander-Scott N, Green TC, Wellenius GA, Weinberger KR. Increased Risk of Opioid Overdose Death Following Cold Weather: A Case-Crossover Study. Epidemiology. 2019 Sep;30(5):637-641. doi: 10.1097/EDE.0000000000001041. PMID: 31205291; PMCID: PMC6679791.
Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ, Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA, Marshall BDL. High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans. Pain. 2019 Sep;160(9):2126-2135. doi: 10.1097/j.pain.0000000000001606. PMID: 31145217; PMCID: PMC6699915.
Reisner SL, Hughto JMW. Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample. PLoS One. 2019 Aug 27;14(8):e0221583. doi: 10.1371/journal.pone.0221583. PMID: 31454395; PMCID: PMC6711503.
Peterson M, Rich J, Macmadu A, Truong AQ, Green TC, Beletsky L, Pognon K, Brinkley-Rubinstein L. “One guy goes to jail, two people are ready to take his spot”: Perspectives on drug-induced homicide laws among incarcerated individuals. Int J Drug Policy. 2019 Aug;70:47-53. doi: 10.1016/j.drugpo.2019.05.001. Epub 2019 May 10. PMID: 31082662; PMCID: PMC7429714.
Becker SJ, Scott K, Murphy CM, Pielech M, Moul SA, Yap KR, Garner BR. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study. BMC Health Serv Res. 2019 Jul 9;19(1):466. doi: 10.1186/s12913-019-4308-6. PMID: 31288797; PMCID: PMC6617614.
Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019 Jul 1;200:59-63. doi: 10.1016/j.drugalcdep.2019.03.014. Epub 2019 May 8. PMID: 31100636; PMCID: PMC6588486.
Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston. J Urban Health. 2019 Jun;96(3):353-366. doi: 10.1007/s11524-019-00365-1. PMID: 31168735; PMCID: PMC6565790.
Kishore S, Hayden M, Rich J. Lessons from Scott County – Progress or Paralysis on Harm Reduction? N Engl J Med. 2019 May 23;380(21):1988-1990. doi: 10.1056/NEJMp1901276. Epub 2019 May 1. PMID: 31042821; PMCID: PMC10347881.
Goedel WC, Green TC, Viner-Brown S, Rich JD, Marshall BDL. Increased overdose mortality during the first week of the month: Revisiting the “check effect” through a spatial lens. Drug Alcohol Depend. 2019 Apr 1;197:49-55. doi: 10.1016/j.drugalcdep.2018.12.024. Epub 2019 Feb 12. PMID: 30776571; PMCID: PMC10416546.
Coffin PO, Rich JD. Overdose Research: 15 Years Later. J Urban Health. 2019 Feb;96(1):1-5. doi: 10.1007/s11524-018-00344-y. PMID: 30623291; PMCID: PMC6391289.
Waye KM, Goyer J, Dettor D, Mahoney L, Samuels EA, Yedinak JL, Marshall BDL. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches. Addict Behav. 2019 Feb;89:85-91. doi: 10.1016/j.addbeh.2018.09.027. Epub 2018 Sep 25. PMID: 30278306; PMCID: PMC6240389.
Bernstein MH, Magill M, Weiss AP, Kaptchuk TJ, Blease C, Kirsch I, Rich JD, Becker SJ, Mach S, Beaudoin FL. Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients. Psychother Psychosom. 2019;88(6):380-382. doi: 10.1159/000503038. Epub 2019 Sep 27. PMID: 31563914; PMCID: PMC6868304.
Dumenco L, Monteiro K, Collins S, Stewart C, Berkowitz L, Flanigan T, Rich J, George P. A qualitative analysis of interprofessional students’ perceptions toward patients with opioid use disorder after a patient panel experience. Subst Abus. 2019;40(2):125-131. doi: 10.1080/08897077.2018.1546262. Epub 2019 Feb 27. PMID: 30810496; PMCID: PMC10499010.
2018
Stone AC, Carroll JJ, Rich JD, Green TC. Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug Alcohol Depend. 2018 Nov 1;192:94-97. doi: 10.1016/j.drugalcdep.2018.07.019. Epub 2018 Aug 25. PMID: 30243145; PMCID: PMC10246725.
Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, Rich JD, Hadland SE, Green TC, Marshall BDL. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018 Nov;61:52-58. doi: 10.1016/j.drugpo.2018.09.009. Epub 2018 Oct 18. PMID: 30344005; PMCID: PMC6701177.
Bernstein MH, Magill M, Beaudoin FL, Becker SJ, Rich JD. Harnessing the placebo effect: a promising method for curbing the opioid crisis? Addiction. 2018 Nov;113(11):2144-2145. doi: 10.1111/add.14385. Epub 2018 Aug 9. PMID: 29989293; PMCID: PMC10395188.
